Furthermore, it addresses the FDA’s communications With all the applicant, the retention of information that help the SE report, confidentiality of an SE report, how an applicant can amend or withdraw an SE report, how an applicant might transfer ownership of the SE report to a whole new applicant and electronic submission on the SE report and am